文献速递消化内镜消化道肿瘤与早癌

计算机辅助检测对结直肠肿瘤无效:非随机研究的系统综述与Meta分析

Lack of Effectiveness of Computer Aided Detection for Colorectal Neoplasia: A Systematic Review and Meta-Analysis of Nonrandomized Studies.
PubMed 文献 · Clin Gastroenterol Hepatol · 2023-12-04

该系统综述与Meta分析纳入8项非随机研究共9782例患者(CADe组4569例,非CADe组5213例),比较CADe辅助结肠镜与标准结肠镜在真实世界中的效果。结果显示两组在腺瘤检出率(44% vs 38%;RR 1.11;95%CI 0.97-1.28)、每次结肠镜平均腺瘤数(0.93 vs 0.79;MD 0.14;95%CI -0.04-0.32)、非肿瘤性病变数及退镜时间上均无显著差异,所有结局证据确定性极低。作者结论认为CADe在非随机研究中既未改善结直肠肿瘤检出,也未增加结肠镜负担。

要点

  • 在真实世界非随机研究中,CADe辅助结肠镜未显著提高腺瘤检出率(44% vs 38%;RR 1.11;95%CI 0.97-1.28)。
  • CADe组与非CADe组每次结肠镜平均腺瘤数无显著差异(0.93 vs 0.79;MD 0.14;95%CI -0.04-0.32)。
  • CADe未显著增加非肿瘤性病变检出数或退镜时间,所有结局证据确定性极低。

核心结论

  • 在真实世界非随机研究中,CADe辅助结肠镜既未改善结直肠肿瘤检出,也未增加结肠镜负担,对随机试验结果的普遍性提出质疑。

研究设计与样本

  • 系统综述与Meta分析,检索MEDLINE、EMBASE、Cochrane和Google Scholar从建库至2023年8月20日。
  • 纳入8项非随机研究,共9782例患者(CADe组4569例,非CADe组5213例),比较CADe辅助与标准结肠镜的效果。
  • 采用风险比(RR)分析二分类变量,均数差(MD)分析连续变量,均给出95%置信区间(CI)。

主要发现

  • 腺瘤检出率:CADe组44% vs 非CADe组38%(RR 1.11;95%CI 0.97-1.28),无显著差异。
  • 每次结肠镜平均腺瘤数:CADe组0.93 vs 非CADe组0.79(MD 0.14;95%CI -0.04-0.32),无显著差异。
  • 每次结肠镜平均非肿瘤性病变数(8项研究):CADe组0.52 vs 非CADe组0.47(MD 0.14;95%CI -0.07-0.34),无显著差异。
  • 退镜时间(6项研究):CADe组14.3分钟 vs 非CADe组13.4分钟(MD 0.8分钟;95%CI -0.18-1.90),无显著差异。
  • 存在显著异质性,所有结局证据确定性均为极低。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 存在显著异质性。
  • 所有结局证据确定性均为极低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Benefits of computer-aided detection (CADe) in detecting colorectal neoplasia were shown in many randomized trials in which endoscopists' behavior was strictly controlled. However, the effect of CADe on endoscopists' performance in less-controlled setting is unclear. This systematic review and meta-analyses were aimed at clarifying benefits and harms of using CADe in real-world colonoscopy. METHODS: We searched MEDLINE, EMBASE, Cochrane, and Google Scholar from inception to August 20, 2023. We included nonrandomized studies that compared the effectiveness between CADe-assisted and standard colonoscopy. Two investigators independently extracted study data and quality. Pairwise meta-analysis was performed utilizing risk ratio for dichotomous variables and mean difference (MD) for continuous variables with a 95% confidence interval (CI). RESULTS: Eight studies were included, comprising 9782 patients (4569 with CADe and 5213 without CADe). Regarding benefits, there was a difference in neither adenoma detection rate (44% vs 38%; risk ratio, 1.11; 95% CI, 0.97 to 1.28) nor mean adenomas per colonoscopy (0.93 vs 0.79; MD, 0.14; 95% CI, -0.04 to 0.32) between CADe-assisted and standard colonoscopy, respectively. Regarding harms, there was no difference in the mean non-neoplastic lesions per colonoscopy (8 studies included for analysis; 0.52 vs 0.47; MD, 0.14; 95% CI, -0.07 to 0.34) and withdrawal time (6 studies included for analysis; 14.3 vs 13.4 minutes; MD, 0.8 minutes; 95% CI, -0.18 to 1.90). There was a substantial heterogeneity, and all outcomes were graded with a very low certainty of evidence. CONCLUSION: CADe in colonoscopies neither improves the detection of colorectal neoplasia nor increases burden of colonoscopy in real-world, nonrandomized studies, questioning the generalizability of the results of randomized trials.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Patel HK, Mori Y, Hassan C, et al. Lack of Effectiveness of Computer Aided Detection for Colorectal Neoplasia: A Systematic Review and Meta-Analysis of Nonrandomized Studies. Clin Gastroenterol Hepatol. 2023. PMID: 38056803. doi:10.1016/j.cgh.2023.11.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。